HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
April 26, 2024 08:30 ET
|
HUTCHMED (China) Limited
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade — — Positive opinion based...
IB Acquisition Corp. Announces Upcoming Automatic Unit Separation
April 26, 2024 08:30 ET
|
IB Acquisition Corp.
Boca Raton, Florida, April 26, 2024 (GLOBE NEWSWIRE) -- IB Acquisition Corp. (NASDAQ: IBACU) (the “Company”) announced today that, on May 1, 2024, the Company’s units will no longer trade, and that...
Exagen Inc. Announces Changes to the Board of Directors
April 26, 2024 08:30 ET
|
Exagen Inc.
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is...
Rigetti Computing Launches the Novera™ QPU Partner Program
April 26, 2024 08:30 ET
|
Rigetti Computing, Inc.
Rigetti Computing announces the launch of the Novera™ QPU Partner Program.
VCI Global Announces Earnings Call and Business Update on April 30th, 2024
April 26, 2024 08:30 ET
|
VCI Global Limited
KUALA LUMPUR, Malaysia, April 26, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), is pleased to announce that it has scheduled an investor...
LiveOne (NASDAQ: LVO) Expands Pay-Per-View Lineup with “KnuckleMania IV”
April 26, 2024 08:30 ET
|
LiveOne, Inc.
Partnering with Bare Knuckle (BKFC) for “Perry vs. Alves" PPV Event on Saturday, April 27, 2024 PPV Tickets Available for $29.99 at LiveOne.com LiveOne Continues to Dominate Live Streaming with...
Bannix Acquisition Corp. Receives Nasdaq Notification of Non-Compliance With Listing Rules
April 26, 2024 08:30 ET
|
Bannix Acquisition Corp.
WEST HOLLYWOOD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (NASDAQ: BNIX) (“Bannix” or the “Company”), a blank check company formed for the purpose of effecting a merger,...
Correction Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team as It Prepares for Market Advancement
April 26, 2024 08:30 ET
|
Sono Group N.V.
MUNICH, Germany, April 26, 2024 (GLOBE NEWSWIRE) -- Sono Group N.V. (the “Company”) (OTC: SEVCF), a solar technology company, today announced a correction to its press release issued on April 25,...
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
April 26, 2024 08:30 ET
|
Biodexa Pharmaceuticals PLC
April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for theTreatment of Familial Adenomatous Polyposis (FAP)...
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
April 26, 2024 08:30 ET
|
Allogene Therapeutics, Inc.
$15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)ALLO-316 Illustrates Proof-of-Concept in RCC...